Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis
Inivata has raised €46M across 1 funding round, most recently a Series B round in Jan 2019. Based in Cambridge, UK; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B | €46M |
| — |
| View deal → |
